AXGN Q4 2021 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q4 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$32M-2.9% YoY

Gross Profit

$26M82.8% margin

Operating Income

-$5M-17.0% margin

Net Income

-$5M-16.8% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+1.1%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$10M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$208M

Total Liabilities

$95M

Stockholders' Equity

$113M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$32M	$32M	-2.9%
Gross Profit	$26M	$27M	-3.4%
Operating Income	-$5M	-$5M	+0.4%
Net Income	-$5M	-$6M	+12.0%